The 2016 PANTS (Personalized Anti-TNF Therapy in Crohn’s disease) protocol, based on a three-year prospective study of over 1000 patients, established a strong link between HLA-DQA1*05 and anti-drug antibody development. Here, HLA-DQA1 is linked to Crohn disease.